Network Pharmacological Analysis and Animal Experimental Study on Osteoporosis Treatment with GuBen-ZengGu Granules

Table 3

Numerical changes in Conn.D, SMI, and BV/TV (mean ± SD, n = 3).

Group	Conn.D (1/mm^3)	SMI	BV/TV (%)
Sham	110.14 ± 5.94	0.609 ± 0.154	0.321 ± 0.011
OVX	26.58 ± 1.99^##	2.153 ± 0.140^##	0.096 ± 0.002^##
EV	70.93 ± 7.30	1.305 ± 0.189	0.211 ± 0.004
GBHD	71.69 ± 3.44	1.387 ± 0.228	0.206 ± 0.007
GBMD	45.14 ± 4.94	1.692 ± 0.063	0.157 ± 0.006
GBLD	32.17 ± 3.24^△△	1.916 ± 0.109^△△	0.120 ± 0.004

Note. Compared with the sham group,  < 0.01; compared with the OVX group,  < 0.01,  < 0.05; compared with the GBHD group,  < 0.01,  < 0.05.